CMW Client Phoenix Life Sciences was featured in an article from Leafly involving their work in diabetes care and treatment.

Next year, Denver-based CBD producer Phoenix Life Sciences International plans to conduct a series of short-term studies with Vanuatu patients using US-imported CBD as a diabetes treatment, beginning with a 1,000-person trial at the country’s main hospital. While the cannabis will be imported at first, Phoenix is also on track to break ground in 2019 on its international cannabis-production hub and 50 acres of growing land on a former military base in Vanuatu, a site now reportedly being “readied” by goats.

Read the FULL ARTICLE HERE